Colorectal Cancer

As majority leader Steve Scalise announces his new cancer diagnosis and author Ibram X. Kendi reveals that he is cancer free, this is what’s happening in the oncology space this week.

Becoming an advocate after my cancer diagnosis made an impact not only on others, but for myself.

The Food and Drug Administration has approved the combination of Lonsurf and Avastin for patients with metastatic colorectal cancer previously treated with chemotherapies, an anti-VEGF therapy and, if RAS wild-type, an anti-EGFR therapy.

If it wasn’t for my friends and family, I don’t know how I would have gotten through cancer alone.

We recently asked our audience of patients, survivors and caregivers about the ongoing cisplatin and carboplatin shortage. Here’s what they had to say.

Having a strong connection with their care team can be crucial for the well-being of LGBTQ+ patients with cancer, as a colorectal cancer survivor and surgeon from City of Hope told CURE®.

Implementing longer intervals between the completion of neoadjuvant therapy and surgery may have a positive effect on pathologic complete responses for patients with locally advanced rectal cancer.

When it comes to a physical exam, you don’t know how much of an impact it could make.

Patients with non-microsatellite instability-high metastatic colorectal cancer had better survival rates from the botensilimab and balstilimab combination.

Recent research found that patients who supplemented their vitamin D intake tended to have improved colorectal cancer outcomes.

Here are a series of poems written about our ordeal with cancer and kicking it to the curb.

I was diagnosed with cancer five years ago, and am extremely grateful for the people I met along the way.

The drug combination of Lonsurf plus Avastin improved survival in patients with pretreated, metastatic, refractory colorectal cancer, according to recently published study findings.

A team from Rutgers University has figured out the science behind once-dormant, self-reviving cells, and the discovery may help predict which patients will experience relapse.

The FDA granted a priority review to Lonsurf with or without Avastin for the treatment of patients with pretreated metastatic colorectal cancer.

The Food and Drug Administration granted botensilimab plus balstilimab a Fast Track Designation to treat certain patients with metastatic colorectal cancer.

Patients with stage 3 colon cancer who reported physical activity after surgical resection may derive a survival benefit and may prolong disease recurrence.

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

Nowadays, I think of myself more as a cancer survivor and advocate than patient. Here's what I learned along the way.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

I’ve had three colonoscopies within five years and am still colorectal cancer-free.

When I was in the throes of cancer, I didn't know how to answer well-meaning people who asked, "How you doin'?"

I’ve had many colonoscopies over the last two decades, so here are my tips for preparing for and going through the procedure.

Hodgkin lymphoma survivors should avoid associated risk factors of developing colorectal cancer such as smoking, alcohol usage and being overweight.

After I was diagnosed with colorectal cancer and told I needed a colectomy, I knew I’d face physical and financial difficulties after the surgery, but I did not anticipate the emotional toll of my diagnosis.

The best of humanity met me at the worst time of my life when I found “my people” after receiving a stage 4 colorectal cancer diagnosis.

Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.

In 2023, my goal is to continue building my role as a patient advocate and to support other cancer survivors in the fight through the various organizations I am involved with.

The PRESERVE 1 trial was discontinued due to responses and survival measures favoring placebo versus Cosela when added to a chemoimmunotherapy regimen.

Postmenopausal women cancer survivors, including lung, breast, colorectal and endometrial cancer, may have a greater physical function decline than is generally expected at their age, which may lead to lower quality of life after treatment.